在COVID-19和结核病中控制的人类感染模型:目前的进展和未来的挑战
Hazel Morrison1, Susan Jackson1, Helen McShane1
1Jenner Institute, University of Oxford, Oxford, United Kingdom.
Frontiers in immunology
|June 12, 2023
概括
控制的人类感染模型 (CHIMs) 正在为结核病和Covid-19研究取得进展. 这些模型有助于研究疾病,测试新的疫苗和治疗方法.
科学领域:
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
背景情况:
- 控制人类感染模型 (CHIM) 对于研究疾病进展和评估干预措施至关重要.
- 针对结核病 (TB) 和Covid-19的CHIM正在开发中,面临着优化挑战.
- 由于道德考虑,我们需要替代模型来处理毒性病原体,如 Mycobacterium tuberculosis.
研究的目的:
- 审查结核病和Covid-19的CHIMs的进展和未来方向.
- 讨论CHIM在了解疾病动力学和免疫反应方面的应用.
- 突出CHIM在评估新型疫苗和治疗方法中的有用性.
主要方法:
- 开发使用替代真菌细菌或结核病转基因菌株的CHIM.
- 使用SARS-CoV-2的鼻腔CHIM来研究病毒动力学和免疫反应.
- 采用CHIMs的各种管理路径 (气溶,支气管,皮内注射).
主要成果:
- CHIM能够详细研究疾病过程,并评估预防/治疗方法.
- SARS-CoV-2 CHIMs用于评估病毒动力学和免疫反应.
- 由于伦理限制,正在开发结核病的替代模型.
结论:
- CHIM是推动结核病和Covid-19研究,疫苗开发和治疗评估的重要工具.
- 对CHIM的持续改进对于其有效应用至关重要.
- COVID-19大流行的动态性质为CHIM发展带来了独特的挑战和机会.
更多相关视频
10:10A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
19.0K
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
19.9K
相关概念视频
Pulmonary Tuberculosis I
287
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
287
Pulmonary Tuberculosis V
214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
